Arcadia Biosciences, Inc. (RKDA)

0.53 +3.31% (+0.02)

Over 1M: -15.2%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

0.4 0.5 0.6 0.7
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 2.4M Q3 '21 — Operating Income: -8.7M Q3 '21 — Free Cash Flow: -8.5M Q3 '21 — Net Income: -2.2M Q4 '21 — Revenue: 2.2M Q4 '21 — Operating Income: -13.8M Q4 '21 — Free Cash Flow: -6.7M Q4 '21 — Net Income: -9.3M Q1 '22 — Revenue: 3.2M Q1 '22 — Operating Income: -4.6M Q1 '22 — Free Cash Flow: -4.9M Q1 '22 — Net Income: -4.5M Q2 '22 — Revenue: 3.9M Q2 '22 — Operating Income: -3.8M Q2 '22 — Free Cash Flow: -3.4M Q2 '22 — Net Income: -3.8M Q3 '22 — Revenue: 1.6M Q3 '22 — Operating Income: -4M Q3 '22 — Free Cash Flow: -3.4M Q3 '22 — Net Income: -2.9M Q4 '22 — Revenue: 744K Q4 '22 — Operating Income: -4.7M Q4 '22 — Free Cash Flow: -2.4M Q4 '22 — Net Income: -4.2M Q1 '23 — Revenue: 1.2M Q1 '23 — Operating Income: -3.9M Q1 '23 — Free Cash Flow: -3.5M Q1 '23 — Net Income: -9.4M Q2 '23 — Revenue: 1.3M Q2 '23 — Operating Income: -1.5M Q2 '23 — Free Cash Flow: -4.8M Q2 '23 — Net Income: 823K Q3 '23 — Revenue: 1.3M Q3 '23 — Operating Income: -1.4M Q3 '23 — Free Cash Flow: -2.9M Q3 '23 — Net Income: -2.6M Q4 '23 — Revenue: 777K Q4 '23 — Operating Income: -1.2M Q4 '23 — Free Cash Flow: -4.1M Q4 '23 — Net Income: -2.9M Q1 '24 — Revenue: 987K Q1 '24 — Operating Income: -1.6M Q1 '24 — Free Cash Flow: -3.2M Q1 '24 — Net Income: -2.4M Q2 '24 — Revenue: 1.3M Q2 '24 — Operating Income: 2M Q2 '24 — Free Cash Flow: -2.5M Q2 '24 — Net Income: 1.1M Q3 '24 — Revenue: 1.5M Q3 '24 — Operating Income: -1.8M Q3 '24 — Free Cash Flow: -1.8M Q3 '24 — Net Income: -1.6M Q4 '24 — Revenue: 1.2M Q4 '24 — Operating Income: -2.3M Q4 '24 — Free Cash Flow: -2.2M Q4 '24 — Net Income: -4.1M Q1 '25 — Revenue: 1.2M Q1 '25 — Operating Income: 530K Q1 '25 — Free Cash Flow: -1.6M Q1 '25 — Net Income: 2.6M Q2 '25 — Revenue: 1.5M Q2 '25 — Operating Income: -501K Q2 '25 — Free Cash Flow: -2M Q2 '25 — Net Income: -4.5M Q3 '25 — Revenue: 1.3M Q3 '25 — Operating Income: -1.2M Q3 '25 — Free Cash Flow: -257K Q3 '25 — Net Income: 856K Q4 '25 — Revenue: 901K Q4 '25 — Operating Income: -1.4M Q4 '25 — Free Cash Flow: -861K Q4 '25 — Net Income: -1.3M Q1 '26 — Revenue: 1.1M Q1 '26 — Operating Income: -779K Q1 '26 — Net Income: -4.4M Q2 '26 — Revenue: 1.4M Q2 '26 — Operating Income: -496K Q2 '26 — Net Income: -6.3M -12M -8M -4M 0 4M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Income Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.9
OE margin -55.5%
Oper. margin -80.1%
Accruals -145.9%
Gross margin 34.6%
EBITDA margin -79.9%
FCF margin -53.4%
OCF margin -53.4%
Profit margin -234.5%
ROA -188.9%
ROCE -89.5%
ROE -1758.5%
Capex / sales —
OCF / EBIT —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.9
ND/EBITDA —
Cash runway 1.6 yr
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 2.9×
F-score 2.2 pts
Cash / Debt —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.7
Sales/sh Y/Y -12.5%
Shares change +0.35%
Sales Q/Q -0.82%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.